What are Rafael Holdings, Inc.'s total assets?

Rafael Holdings, Inc. (RFL) holds $92.0M in total assets, down 14.9% year over year.

How much cash does Rafael Holdings, Inc. have?

Rafael Holdings, Inc. holds $30.5M in cash and equivalents.

Can Rafael Holdings, Inc. cover its short-term obligations?

Its current ratio is 3.16 — current assets exceed current liabilities.

Where does Rafael Holdings, Inc.'s balance sheet data come from?

Every line is extracted from Rafael Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Rafael Holdings, Inc. RFL Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q3 '26	Q2 '26	Q1 '26	Q4 '25	Q3 '25
Cash and cash equivalents	$30.5M-19.3%	$37.78M-17.0%	$45.54M-13.7%	$52.77M+39.1%	$37.94M+1,797%
Accounts receivable, net	$294K-0.3%	$295K-28.6%	$413K-34.1%	$627K+51.4%	$414K+107%
Inventories	$276K+1.8%	$271K-0.4%	$272K-3.2%	$281K-2.4%	$288K+10,373%
Prepaid expenses and other current assets	$872K-0.1%	$873K+70.2%	$513K-34.7%	$786K-6.1%	$837K+15.4%
Total current assets	$34.86M-17.9%	$42.45M-12.2%	$48.32M-14.8%	$56.71M+33.6%	$42.44M-35.5%
Property and equipment, net	$1.52M-1.4%	$1.55M-1.1%	$1.56M-2.1%	$1.6M-1.1%	$1.61M-16.5%
Accumulated depreciation	$1.07M+1.9%	$1.05M+2.0%	$1.03M+1.5%	$1.01M+1.9%	$993K-9.4%
Goodwill	$19.94M0.0%	$19.94M0.0%	$19.94M0.0%	$19.94M-29.5%	$28.28M—
Intangible assets, net	$896K-3.6%	$929K-3.4%	$962K-3.2%	$994K-3.2%	$1.03M-42.5%
Deferred tax assets	$138K0.0%	$138K0.0%	$138K0.0%	$138K-98.5%	$9M+21,918%
Other non-current assets	$2.12M+14.3%	$1.86M0.0%	$1.86M0.0%	$1.86M+8.1%	$1.72M-94.0%
Equity method investments	$750K—	——	——	——	——
Long-term investments	——	$250M-50.0%	$500M—	——	——
Total assets	$91.99M-7.4%	$99.32M-5.8%	$105.38M-7.7%	$114.11M+5.6%	$108.1M+30.2%
Accounts payable	$7.04M-13.8%	$8.17M+20.3%	$6.79M-1.4%	$6.89M-11.5%	$7.79M+206%
Accrued expenses	$2.76M-55.9%	$6.26M-19.3%	$7.76M+7.8%	$7.2M+35.5%	$5.31M+12.9%
Accrued compensation	$797K-13.0%	$916K-10.4%	$1.02M-13.3%	$1.18M—	——
Current portion of long-term debt	——	——	——	——	——
Accrued interest	$248K+2.1%	$243K+2.5%	$237K+0.9%	$235K+2.6%	$229K-0.9%
Total current liabilities	$11.02M-10.8%	$12.36M+2.3%	$12.08M+4.1%	$11.6M+5.2%	$11.03M+55.1%
Deferred tax liabilities	——	——	——	$9.16M—	——
Other non-current liabilities	$27K0.0%	$27K0.0%	$27K0.0%	$27K+8.0%	$25K-63.2%
Total liabilities	$11.19M-30.3%	$16.06M-0.9%	$16.2M+2.9%	$15.74M-33.3%	$23.58M+125%
Common stock	——	——	——	——	$9.4M—
Additional paid-in capital	$323.23M0.0%	$323.08M+0.1%	$322.73M+0.2%	$322.16M+8.6%	$296.65M+5.6%
Retained earnings	-$252.72M-1.7%	-$248.5M-2.7%	-$242.08M-4.2%	-$232.26M-5.5%	-$220.17M-2.2%
Accumulated other comprehensive income (loss)	$3.9M+0.6%	$3.87M+1.3%	$3.82M+1.0%	$3.79M+1.6%	$3.73M+0.1%
Noncontrolling interests	$5.42M+32.5%	$4.09M+2.3%	$4M+0.5%	$3.98M+1.0%	$3.94M—
Total stockholders' equity	$75.39M-4.8%	$79.17M-7.1%	$85.18M-9.8%	$94.39M+17.1%	$80.58M+16.1%
Total liabilities and stockholders' equity	$91.99M-7.4%	$99.32M-5.8%	$105.38M-7.7%	$114.11M+5.6%	$108.1M+30.2%
Allowance for Doubtful Accounts Receivable (Current)	$245K0.0%	$245K0.0%	$245K0.0%	$245K0.0%	$245K0.0%
Other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025)	——	——	——	$1.21M—	——
Prepaid Clinical Costs	$2.92M-9.6%	$3.23M+104%	$1.58M+51.6%	$1.05M—	——
Other Receivables	——	——	——	$1.21M—	——
Deferred Tax Assets and Other Non-Current Assets	$80K+186%	$28K-3.4%	$29K-14.7%	$34K-17.1%	$41K+105%
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)	$130K0.0%	$130K0.0%	$130K0.0%	$130K0.0%	$130K+4.8%
Finite-Lived Intangible Assets - Expected Amortization Expense (Year Five)	$344K0.0%	$344K0.0%	$344K0.0%	$344K-27.4%	$474K-60.8%
Finite Lived Intangible Assets - Gross	$1.04M0.0%	$1.04M0.0%	$1.04M0.0%	$1.04M0.0%	$1.04M-46.7%
Intangible assets — net	$896K-3.6%	$929K-3.4%	$962K-3.2%	$994K-3.2%	$1.03M-42.5%
Other intangible assets—net	$896K-3.6%	$929K-3.4%	$962K-3.2%	$994K-3.2%	$1.03M-42.5%
Investments	——	$250M-50.0%	$500M—	——	——
Investments and Cash	——	——	——	$1.5M+158%	$582K-61.2%
Investments	$750K0.0%	$750K+50.0%	$500K—	——	——
Other Assets	$2.12M+14.3%	$1.86M0.0%	$1.86M0.0%	$1.86M+8.1%	$1.72M-94.0%
Other non-current assets	$80K+186%	$28K-3.4%	$29K-14.7%	$34K-17.1%	$41K+105%
Property, plant and equipment at cost	$2.59M0.0%	$2.59M+0.2%	$2.59M-0.7%	$2.61M0.0%	$2.61M-13.9%
Software and Technology Licenses, Net	$80K+186%	$28K-3.4%	$29K-14.7%	$34K-17.1%	$41K+105%
Tax Credit Carryforward Valuation Allowance	——	——	——	$128.4M—	——
Accrued liabilities and other current	$3.9M+875%	$400K—	——	$3.6M—	——
Other Commercial Liabilities	$2.76M-0.5%	$2.78M-28.0%	$3.86M+16.8%	$3.3M+77.1%	$1.87M+32.2%
Convertible Debt - Current	$608K0.0%	$608K—	——	$614K0.0%	$614K0.0%
Accrued Liabilities, Current	$2.76M-0.5%	$2.78M-28.0%	$3.86M+16.8%	$3.3M+77.1%	$1.87M+32.2%
Due To Related Parties	$70K+6.1%	$66K+4.8%	$63K-4.5%	$66K-90.1%	$664K-9.2%
Lease Liability Payments - 2020 (Remaining Three Months)	$46K-49.5%	$91K-33.6%	$137K—	——	——
Operating Lease Liability Payments - 2024 (Lessee)	$31K0.0%	$31K0.0%	$31K-83.5%	$188K—	——
Operating Lease Liability Payments - 2025 (Lessee)	$31K0.0%	$31K0.0%	$31K-83.5%	$188K—	——
Lease Liability Payments - Due Year Two	$31K0.0%	$31K0.0%	$31K-83.5%	$188K—	——
Lease Liability Payments - Remainder of Fiscal Year	$188K0.0%	$188K0.0%	$188K+3.9%	$181K—	——
Operating Lease Liability Payments Due	$265K-14.5%	$310K-12.9%	$356K-11.0%	$400K—	——
Professional Service Fees Payable	$415K-1.7%	$422K-23.1%	$549K+34.9%	$407K+57.8%	$258K+43.3%
Settlement Liabilities (Current)	——	$400K—	——	——	——
Convertible Debt (Non-Current)	$2K-96.2%	$52K-7.1%	$56K-28.2%	$78K+2.6%	$76K+1.3%
Deferred Tax Liabilities - Unrealized Gains on Trading Securities	——	——	——	$199K—	——
Operating Lease Liability Payments - 2026 (Lessee)	$31K0.0%	$31K0.0%	$31K0.0%	$31K—	——
Accrued expenses and other liabilities	——	$3.48M-10.6%	$3.9M+0.1%	$3.9M+13.1%	$3.45M+4.6%
Accrued taxes and other expenses	$2.76M-55.9%	$6.26M-19.3%	$7.76M+7.8%	$7.2M+35.5%	$5.31M+12.9%
Total debt	——	——	——	——	——
Unrecognized Tax Benefits	——	——	——	$16.98M—	——
AOCI - Available-for-Sale Securities, Net of Tax	$624K+74.3%	$358K0.0%	$358K0.0%	$358K+63.5%	$219K+62.2%
Additional paid-in capital	$323.23M0.0%	$323.08M+0.1%	$322.73M+0.2%	$322.16M+8.6%	$296.65M+5.6%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	——	——	——	——	$9.4M—
Number of Exercisable Options	1.2M+11.2%	1.1M+22.4%	917.5K+147%	371.8K+57.2%	236.6K+7.7%
Other Equity	$100M0.0%	$100M0.0%	$100M0.0%	$100M0.0%	$100M0.0%
Share-Based Payment Award Options Outstanding - Number	1.7M0.0%	1.7M0.0%	1.7M+1.5%	1.7M+59.9%	1M+61.9%
Warrants and Rights Outstanding	645.2K0.0%	645.2K-39.0%	1.1M-0.1%	1.1M0.0%	1.1M—
Weighted Average Exercise Price of Outstanding Options	$6.310.0%	$6.310.0%	$6.31-5.1%	$6.650.0%	$6.65-30.4%
Cumulative Cost Basis	$2.59M0.0%	$2.59M+0.2%	$2.59M-0.7%	$2.61M0.0%	$2.61M-13.9%
Fair Value Measurement Disclosure	$2.7M0.0%	$2.7M0.0%	$2.7M0.0%	$2.7M0.0%	$2.7M0.0%
Accrued liabilities	——	$3.48M-10.6%	$3.9M+0.1%	$3.9M+14.6%	$3.4M+3.0%
Accrued bonuses	$767K+37.0%	$560K-40.9%	$948K+16.5%	$814K+32.4%	$615K+79.8%
Accrued Clinical Trial Expense	$381K-5.0%	$401K-55.2%	$896K+56.9%	$571K—	——
Accrued Compensation and Benefits	——	——	$147K-49.8%	$293K—	——
Professional service fees	$415K-1.7%	$422K-23.1%	$549K+34.9%	$407K+57.8%	$258K+43.3%
Allowance for doubtful accounts	$245K0.0%	$245K0.0%	$245K0.0%	$245K0.0%	$245K0.0%
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	——	——	——	——	——
Gross Unrealized Gains	——	——	——	——	——
Class of Warrant or Right, Outstanding	$645.19K0.0%	$645.19K-39.0%	$1.06M-0.1%	$1.06M0.0%	$1.06M—
Common stock, par value (in dollars per share)	——	——	——	——	——
Long-term debt, net	$2K-96.2%	$52K-7.1%	$56K-28.2%	$78K+2.6%	$76K+1.3%
Convertible Note Receivable Noncurrent	$2.12M+14.3%	$1.86M0.0%	$1.86M0.0%	$1.86M+8.1%	$1.72M+51.5%
Short-term debt and current portion of long-term debt	——	——	——	——	——
Deferred Tax Liabilities, Gross	——	——	——	$9.16M—	——
Deferred income taxes	$138K0.0%	$138K0.0%	$138K0.0%	$138K-98.5%	$9M—
Deferred Tax Asset Disallowed Interest Expense	——	——	——	$1.01M—	——
Disallowed business interest expense carryforward	——	——	——	$853K—	——
Deferred Tax Assets, Charitable Contribution Carryforwards	——	——	——	$346K—	——
Deferred Tax Assets Depreciation	——	——	——	$340K—	——
Deferred Tax Assets, Gross	——	——	——	$137.42M—	——
Deferred Tax Assets Research And Experimental Expenditures	——	——	——	$29.12M—	——
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost	——	——	——	$2.35M—	——
Reserve for uncertain tax position	——	——	——	$647K—	——
Deferred Tax Assets, Valuation Allowance	——	——	——	$128.4M—	——
Federal and state intangible assets	——	——	——	$8.96M—	——
Employee Retention Credits Amount	——	——	——	$236K—	——
Finite-Lived Intangible Assets, Accumulated Amortization	-$144K-29.7%	-$111K-42.3%	-$78K-69.6%	-$46K-254%	-$13K-108%
2028	$130K0.0%	$130K0.0%	$130K0.0%	$130K0.0%	$130K+4.8%
2030	$130K0.0%	$130K0.0%	$130K0.0%	$130K0.0%	$130K+4.8%
2031	——	——	——	$130K—	——
Remainder of 2026	$32K-50.8%	$65K-33.7%	$98K—	——	$33K-54.2%
2027	$130K0.0%	$130K0.0%	$130K0.0%	$130K0.0%	$130K-2.3%
2029	$130K0.0%	$130K0.0%	$130K0.0%	$130K0.0%	$130K+4.8%
Finite Lived Intangible Assets Amortization Expense After Year Five	$344K0.0%	$344K0.0%	$344K0.0%	$344K-27.4%	$474K-60.8%
Gross Carrying Amount	$1.04M0.0%	$1.04M0.0%	$1.04M0.0%	$1.04M0.0%	$1.04M-46.7%
Inprocess Research And Development Noncurrent	$31.58M0.0%	$31.58M0.0%	$31.58M0.0%	$31.58M0.0%	$31.58M+1,905%
Lessee Operating Lease Liability Payments Due	$265K-14.5%	$310K-12.9%	$356K-11.0%	$400K—	——
Membership Offering Unit Percentage	——	——	——	——	——
Noncontrolling interests in subsidiaries	$5.42M+32.5%	$4.09M+2.3%	$4M+0.5%	$3.98M+1.0%	$3.94M+23.8%
Noncurrent Prepaid Clinical Costs	$244K0.0%	$244K-61.2%	$629K-55.0%	$1.4M—	——
Other accrued liabilities	$156K-33.9%	$236K+13.5%	$208K+112%	$98K-77.4%	$433K+35.3%
Other Additional Capital	$100M0.0%	$100M0.0%	$100M0.0%	$100M0.0%	$100M0.0%
Contributions from noncontrolling interests	——	——	——	——	——
Percentage Of Favorable Discount To Financing Costs	——	25%—	——	——	——
Sale of stock, price per share (in dollars per share)	$0.01—	——	——	——	$0.010.0%
Settlement Liabilities, Current	——	$400K—	——	——	——
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number	$1.25M+11.2%	$1.12M+22.4%	$917.49K+147%	$371.85K+57.2%	$236.56K+7.7%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	$1.68M0.0%	$1.68M0.0%	$1.68M+1.5%	$1.65M+59.9%	$1.03M+61.9%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$6.310.0%	$6.310.0%	$6.31-5.1%	$6.650.0%	$6.65-30.4%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$7.75-6.6%	$8.3-14.6%	$9.72-34.9%	$14.94+428%	$2.83-78.4%
Unrecognized tax benefits	——	——	——	$16.98M—	——
Remainder of Fiscal Year 2024	$46K-49.5%	$91K-33.6%	$137K—	——	$33K-47.6%
Remainder of Fiscal Year 2025	$32K-50.8%	$65K-33.7%	$98K—	——	$33K-54.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Rafael Holdings, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Rafael Holdings, Inc.'s total assets?: Rafael Holdings, Inc. (RFL) holds $92.0M in total assets, down 14.9% year over year.
How much cash does Rafael Holdings, Inc. have?: Rafael Holdings, Inc. holds $30.5M in cash and equivalents.
Can Rafael Holdings, Inc. cover its short-term obligations?: Its current ratio is 3.16 — current assets exceed current liabilities.
Where does Rafael Holdings, Inc.'s balance sheet data come from?: Every line is extracted from Rafael Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.